The impact of protein biochips and microarrays on the drug development process

Huels, Christoph; Muellner, Stefan; Meyer, E.; Cahill, Dolores J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The impact of protein biochips and microarrays on the drug development process

MPS-Authors

Cahill, Dolores J.
Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Huels, C., Muellner, S., Meyer, E., & Cahill, D. J. (2002). The impact of protein biochips and microarrays on the drug development process. Drug Discovery Today, 7(18), 119-124.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-8BA9-E

Abstract

With the genome sequences of several organisms now in public databases, the scientific community has realized that it is time to prepare for the next step: the understanding of biological systems or systems biology. Whereas genes contain the information for life, the encoded proteins and RNAs fulfill nearly all the functions, from replication to regulation. At present, there is a perceived demand for high-throughput and parallel analytical devices as research tools in systems biology, and, in addition, for new concepts to extract knowledge and value from these data. Protein biochips will play a decisive role in meeting this need in the future.